Previous 10 | Next 10 |
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of ViewRay, Inc. (“ViewRay” or the “Company”) (NASDAQ: VRAY ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...
CLEVELAND , Sept. 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Penn State Health has entered into a master agreement for the purchase of up to four MRIdian systems, placing an order for its first system today. Penn State Health, which includes the Milton S. H...
Noteworthy events during the week of September 15 - 21 for healthcare investors. More news on: CRISPR Therapeutics AG, Pluristem Therapeutics Inc., GlaxoSmithKline plc, Healthcare stocks news, , Read more ...
ViewRay (NASDAQ: VRAY ) announces that Stanford, CA-based Stanford Health Care will acquire a MRIidian radiotherapy device, apparently under a collaboration agreement, although it does provide the details of said agreement. More news on: ViewRay, Inc., Healthcare stocks news, Read mo...
CLEVELAND , Sept. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Stanford Health Care in Stanford, California , will acquire a MRIdian, the world's leading MR-guided radiation therapy system. MRIdian integrates MRI technology, radiation delivery, and...
CLEVELAND , Sept. 10, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® and MRIdian Linac MRI-guided radiation therapy systems will be featured at the 2019 Annual Meeting of the American Society for Radiation Oncology (ASTRO), being he...
Shares of medical-device maker ViewRay (NASDAQ: VRAY) tumbled 56% in August, according to data provided by S&P Global Market Intelligence . That more than erased the gains the stock had seen during the first half of the year, as shares dropped to their lowest point since ...
CLEVELAND , Aug. 27, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a physician-led informational discussion for investors and analysts during the 2019 American Society of Radiation Oncology (ASTRO) Annual Meeting in Chicago . ...
This Weekly Short Newsletter is normally exclusive to PRO+ Subscribers. We're making this one available to all readers. SA PRO+ is our institutional-grade subscription offering targeted to buysiders and serious investors. If you enjoyed this report, and would like to subscribe or learn more ...
CLEVELAND , Aug. 19, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...